Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2012 Jul 6;48(4):390–397. doi: 10.1002/ppul.22608

A 4 year prospective study to determine risk factors for severe community acquired pneumonia in children in southern China

Qingli Zhang 1,2, Zhongqin Guo 3, Zhenjiang Bai 2, Noni E MacDonald 4,
PMCID: PMC7168025  PMID: 22778084

Abstract

Background

Pneumonia is the major cause of death under 5 years. With high CAP numbers in China and growing access to PICUs, factors associated with severe CAP need to be determined to optimize care.

Objective

To prospectively determine PICU CAP admission features and outcomes.

Methods

A 4 year prospective study of CAP aged 1 month to <14 years admitted to PICU, Children's Hospital Affiliated to Soochow University, China. All were managed in a standard manner. Clinical, laboratory, and imaging findings were collected systematically. All received antibiotics.

Results

Eight hundred ten (7%) of 10,836 CAP hospital admissions needed PICU. Seven hundred seven (87%) were enrolled. PICU CAP children were young (76% ≤ 12 months) and 33% had co‐morbid conditions; 21% congenital heart disease.21% required mechanical ventilation. The average length of PICU stay was 5 days (range, 3–27). The case fatality rate was 5.8%. Viruses were detected in 38%, RSV 24%; bacteria in 23%, Streptococcus pneumoniae 7%, Haemophilus influenza b 4%, Mycoplasma 11%. On single factor analysis, PICU admission respiratory rate >70/min, grunting/groaning, head nodding, cyanosis, and anemia were associated with respiratory failure and with fatality. On multivariate analysis only presence of congenital heart disease, Trisomy 21 and immunodeficiency correlated with fatality; not microbe nor PICU findings.

Conclusions

Young age and underlying congenital heart disease were associated factors for PICU support in CAP in China. Early referral if altered sensorium, high respiratory rate, head nodding, grunting and anemia, and universal access to conjugated vaccines may decrease morbidity and mortality. Pediatr Pulmonol. 2013; 48:390–397. © 2012 Wiley Periodicals, Inc.

Keywords: Community acquired pneumonia, acute lower respiratory tract infection, children, hospitalized, developing country, intensive care, risk factors, China

INTRODUCTION

Pneumonia is well recognized as the leading cause of death for children under the age of 5 years worldwide with more children in this age group dying from pneumonia than from AIDS, malaria and tuberculosis combined.1 In this age group, pneumonia is responsible for about 19% of all deaths.1, 2 Of all community acquired pneumonia (CAP) cases, an estimated 7–13% are severe enough to require hospitalization.1 Of the estimated 156 million new episodes of childhood pneumonia each year worldwide, 151 million episodes are in the developing countries.1 Simply because of their very large populations, the majority of cases occur in India (43 million), China (21 million), and Pakistan (10 million), with additional high numbers in Bangladesh, Indonesia, and Nigeria (6 million each). All are developing countries with emerging economies; some more than others. In 2010–2011, their gross domestic product based on purchasing‐power‐parity (PPP) per capita range from China 92nd of 183 countries at $8,382, Indonesia 122nd at $4666, India 129th at $3,694, Nigeria 141st $2,578, and Bangladesh 155th at $1,693.3 Of note, Norway was in 4th place with $53, 471 per capita.

Given the very high number of children in China and India with CAP and the growing access to intensive care in these countries, factors associated with very severe CAP pneumonia requiring pediatric intensive care (PICU) need to be determined to better optimize care programs and outcomes. A Medline search in 2006 using the terms “pneumonia or acute lower respiratory infection, children, risk factors, developing country, hospitalized” revealed only 26 studies none of which focused on risk factors for need for intensive care nor subsequent outcomes. Substituting the term China or India for developing country in the search added no studies. A broader search with the terms “community acquired pneumonia, children, intensive care” revealed few relevant articles in a developing country among the 35 retrieved. None of those retrieved were particularly helpful as the PICU cohort was too small to delineate risk factors for ventilation and fatality,4 the study were focused on hospital not PICU factors,5 or was predominately centered on a specific pathogen.6, 7 Hence in 2007, a 4 year prospective study in a large children's hospital in southern China was under taken to determine presenting PICU admission features, factors associated with need for mechanical ventilation, length of stay and risk of fatality in children with community acquired pneumonia severe enough to require intensive care.

METHODS

Patients and Clinical Samples

This 4 year prospective study was carried out from January 1, 2007 to December 31, 2010 in the 10 bed PICU, Children's Hospital Affiliated to Soochow University. This Children's Hospital serves as the pediatric tertiary care referral center for admissions for those <14 years of age in the Greater Suzhou Area and the immediate surrounding region in southern China. On average there are 25,000 children admitted each year including on average 600 PICU admissions. In 2006, there were 8.26 million people in Suzhou itself with a pediatric population (0–14 years) of 1.2 million in 2006. By 2010, the population in Suzhou had risen to 13 million with a pediatric population of 1.5 million.

To be eligible for participation in the study, the child needed to be aged 1 month up to 14 years of age, be admitted with community acquired pneumonia to the PICU within 24 hr of hospitalization and have met the World Health Organization criteria for severe or very severe pneumonia.8 Children with co‐morbidities such as meningitis, chronic respiratory diseases or infection with pandemic H1N1 influenza were excluded.

All children with pneumonia in the PICU were managed in a standard manner by protocol. This included on PICU admission verification of the history, a general physical examination with particular focus on chest examination, a chest X‐ray, a complete blood count, blood culture, serum electrolytes, arterial blood gas analysis, liver and renal function tests and nasopharyngeal aspirates for detection of respiratory syncytial virus, adenovirus, influenza virus and parainfluenza virus using direct immuno‐fluorescence assays (Chemicon International, Inc., Temecula, CA). Deep endotracheal aspirates, if the child was intubated, were sent for routine bacterial culture. For detection of Mycobacterium tuberculosis, in selected cases where there was a history of night sweats, poor nutrition, and afternoon tidal fevers, gastric aspirates and/or sputum were sent for smear and culture. Paired serum samples were taken 2 weeks apart for testing for Mycoplasma pneumoniae using specific MP‐IgM, IgG antibodies measured by quantitative ELISA (Serion Immundiagnostica & Institut Virion/Serion GmbH, Germany). Other laboratory and imaging investigations included chest magnetic resonance imaging if extensive consolidation on routine chest film, assessment of coagulation and other factors when clinically indicated. All children routinely received antibiotics on admission to the PICU.

Criteria for assisted ventilation was patterned after guidelines from South Africa9 and included the following: (i) failure to maintain a saturation of >90% on an FIO2 of >70% (i.e., on a poly mask); or if the partial pressure of arterial oxygen (PaO2):FIO2 ratio is <100 (normal is 350); (ii) apnea; (iii) hypercarbia with resulting acidemia (pH < 7.25); and/or (iv) clinical assessment of impending exhaustion due to ongoing high respiratory rate and/or severe chest‐wall indrawing.

All demographic and laboratory data were collected in a systematic manner.

Statistical Analysis

All statistical analyses were done using SPSS 13.0 software. The χ2 test or Fisher's exact test was used to compare categorical variables between fatal and non‐fatal cases, cases requiring mechanical ventilation versus not and those with prolonged PICU stay. Abnormal laboratory findings were compared by rank test. Univariate analyses were done to determine risk factors significantly associated with severity of CAP in the PICU. To determine the independent contribution of each factor towards case outcomes, multiple logistic regression analysis was done. P < 0.05 was considered statistically significant.

Funding, Ethical Approval, and Consent

The study was approved by the Research Ethics Board of the Children's Hospital affiliated with Soochow University. Written informed consent was obtained from all subject's parents before study enrollment. Funding came from Soochow University.

RESULTS

Over the 4 year period, 10,836 children within the eligible age range were admitted to the hospital with community acquired pneumonia (CAP). Of these, 810 (7%) met eligibility criteria for admission to the PICU. Of the 810 admitted to the PICU, 103 (13%) were not enrolled. Of these 103 cases, 76 cases were excluded because parents refused consent and 27 because of other criteria; 23 with pH1N1, 2 with underlying bacterial meningitis and 2 with underlying chronic respiratory diseases. Of the 707 who were enrolled, 671 (95%) were directly admitted to PICU and 36 were transferred from the ward within 24 hr of hospital admission. All had received antibiotics prior to admission to the PICU. All had been breast fed; for older children at least for 1 year.

Of note none had received influenza vaccine, conjugated pneumococcal or Haemophilus influenzae b vaccines as this is not part of routine care in China but all had received BCG vaccine.

The demographics are shown in Table 1. Of the 707 patients, 63% (446/707) were male; gender ratio 1.7 to 1. The mean age was 4 months (range, 1–180 months) with 76% (535/707) under <12 months of age. None were over 5 years of age. The average length of stay in PICU for CAP was 5 days (range, 3–27 days). The CAP PICU case fatality rate was 5.8% (41/707).

Table 1.

Demographics and Outcome of the 707 Children With Severe Community Acquired Pneumonia Admitted PICU

Age–mean in months Number, N (% or range)
Median 4 range (1,120)
 1 m 93 (13)
 2 m 158 (22)
 3 m 80 (11)
 4 m 5 (1)
 5 m 34 (5)
 6–12 m 165 (23)
 >12 m ⩽ 24 m 50 (7)
 >24 m 71 (10)
Gender, % male 446 (63)
Outcome
 Number that needed oxygen 707 (100)
 Number that required Mechanical ventilation 151 (21)
 Length of mechanical ventilation (days) 7 (2, 22)
 Length of PICU stay (days) 7 (4, 25)
 Death 41 (6)

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

In 235 (31%), an underlying co‐morbid condition was present (Table 2). Underlying congenital heart disease was most common (147/235(63%)) with 66 (45%) having a ventricular septal defect, 36 (24%) an atrial septal defect and another 37(25%) both atrial and ventricular septal defects. Only 8 (5%) had cyanotic heart disease. In 205 (91%) of those with an underlying condition, this diagnosis was known prior to admission for severe CAP. However, 28 children with congenital heart disease (19%) and two with immunodeficiency were diagnosed during the PICU admission.

Table 2.

Underlying Conditions in Children Admitted With Severe Community Acquired Pneumonia in the PICU

Co‐morbid conditions, N = 235 (33% total) Diagnosis: known prior to PICU admission Diagnosis: during PICU admission
Congenital heart disease no Trisomy 21 syndrome 109 28
Congenital heart disease and Trisomy 21 syndrome 10 0
Trisomy 21 syndrome 25 0
Cerebral palsy or other neurodevelopmental condition 25 0
Premature birth (<37 weeks) 18 0
Malnutrition 15 0
Immune deficiency 5 2

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

Presenting abnormal clinical and laboratory findings on admission to the PICU are shown in Table 3. All had cough and retractions and 79% (558) had fever over 38°C rectally. Severe respiratory distress, lethargy or decreased level of consciousness were uncommon with each found in only 10% but diarrhea was present in 210 (30%) on admission. In 86% (608/707) of the children, chest radiograph showed consolidation or significant infiltrates on admission to the PICU. In the rest, the findings were increased pulmonary markings and/or small infiltrates. In 136 (19%) magnetic resonance imaging of the chest was also done; all had consolidation or infiltrates but 13 (2%) also had pleural effusions and thickened pleura.

Table 3.

Risk Factors in PICU Admission for Severe Community Acquired Pneumonia in PICU in Suzhou in China

Characteristics Children Children needing prolonged PICU stay Children needing mechanical ventilation Outcome
Number N = 707 (%) Yes, N = 458 (%) No, N = 249 (%) Yes, N = 151 (%) No, N = 556 (%) Fatal, N = 41 (%) Non‐fatal, N = 666 (%)
Age < 12 months 586 (83) 370 (81) 216 (87) 98 (65) 350 (63) 34 (83) 503 (76)
Sex: males 446 (63) 297 (65) 149 (60) 97 (64) 349 (63) 30 (73) 416 (62)
Altered sensorium 219 (31) 167 (36) 52 (21) 68 (45) 151 (27) 38 (93) 181(27)*
Respiratory rate >70/min 395 (51) 316 (69) 79 (32)* 143 (95) 252 (45)* 39 (95) 356 (53)*
Wheezing 256 (36) 87 (19) 169 (68)* 8 (5) 248 (45)* 1 (2) 255 (38)*
Grunting/groaning 398 (56) 348 (76) 50 (20)* 135 (89) 263 (47)* 40 (98) 358 (54)*
Head nodding 152 (21) 130 (28) 22 (9) 89 (59) 63 (11)* 31 (76) 121 (18)*
Cyanosis 289 (41) 241 (53) 48 (19)* 109 (72) 180 (32)* 37 (90) 252 (38)*
Pallor 135 (19) 101 (22) 34 (14) 32 (21) 102 (18) 31 (76) 104 (16)
Oxygen saturation <90% at arrival 318 (45) 287 (63) 31 (12)* 113 (75) 205 (37)* 38 (93) 280 (42)*
Hemoglobin <8 g/dL 80 (11) 67 (15) 13 (5) 63 (42) 17 (3)* 25 (61) 55 (8)*
Abnormal Leukocyte count, (per mm3) low: <4,000 or high > 10,000 360 (51) 312 (68) 45 (18)* 98 (65) 349 (63) 19 (46) 338/653 (52)
Abnormal Glucose (>6.2 mmol/L, <2.5 mmol/L) 452 (64) 271 (59) 160 (64) 87 (58) 344 (62) 39 (5) 394/639 (56)*
Creatine kinase >225 (U/L) 282 (40) 173 (38) 128 (51) 80 (53) 221 (40) 16 (39) 285/666 (43)
Creatine kinase‐MB fraction (>26 U/L) 286 (40) 192 (42) 103 (41) 76 (50) 219 (39) 26 (63) 272/599 (45)*
Lactate dehydrogenase >382 (U/L) 395 (56) 251 (55) 105 (42) 81 (54) 275 (49) 30 (73) 329/607 (54)*
Cr > 84 (µmol/L) 7 (1) 5 (1) 2 (1) 2 (1) 5 (1) 1 (2) 6/666 (1)
Aspartate aminotransferase >67 (U/L) 177 (25) 105 (23) 53 (21) 36 (24) 122 (22) 13 (32) 147/600 (25)
Alanine aminotransferase >35 (U/L) 198 (28) 142 (31) 22 (13) 44 (29) 131 (24) 10 (24) 166/600 (28)
C‐reactive protein >8 (mg/L) 247 (35) 153 (33) 68 (27) 57 (38) 154 (29) 20 (49) 204/602 (34)
*

P < 0.05.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

Overall, 21% (151/707) required mechanical ventilation. Significant factors predictive of respiratory failure on admission were abnormal respiratory findings such as head nodding, grunting, cyanosis, respiratory rate over 70/min as well as anemia on single factor analysis (all P < 0.05; Table 3). A total of 458/707 (65%) stayed in the PICU for more than 5 days (Table 3). When the 41 fatal cases were compared to the 666 survivors on single factor analysis, admission respiratory rate >70/min, grunting/groaning, cyanosis, oxygen saturation <90% at arrival and hemoglobin <8 g/dl were each associated (all P < 0.05; Table 3). Laboratory findings associated with fatality were abnormal glucose either high or low (>6.2 mmol/L, <2.5 mmol/L), CK‐MB(>26 U/L)and lactate dehydrogenase(LDH >382 U/L; all P < 0.05; Table 3).

A causative agent was detected in 61% of the cases with viral agents predominating over bacteria 38% (269/707) versus 23% (162/707; P < 0.001; Table 4). Of the viral causes, respiratory syncytial virus was most common, that is, 63% of the 255 with similar rates in those with congenital heart disease versus those with no co‐morbidity (57% vs. 61% P > 0.05). Mycoplasma was the most common bacterial pathogen accounting for 11% of total cases but 47% of those in whom bacteria was detected. Blood cultures were positive in only 5, that is, 0.7%; two with Streptococcus pneumoniae, two with Haemophilus influenzae b and one with Staphylococcus aureus. In two others, the isolated bacteria was thought to be contaminates: Bacillus species, coagulase negative Staphyloccocus. In nine children, tuberculosis was diagnosed based upon positive gastric aspirate or sputum smears for M. tuberculosis. Of the six children with pleural fluid cultures, four were negative; one grew Streptococcus pneumoniae and one Staphylococcus aureus. Both of these also had positive blood cultures. Concurrent viral and bacterial infection did occur but was not more frequently with S. pneumoniae than with Haemophilus influenzae b cases (20% vs.12%, P > 0.05). No patient with Mycoplasma had a concurrent viral infection detected.

Table 4.

Pathogens Detected With Children With and Without Underlying Conditions With Severe Community Acquired Pneumonia

Underlying condition No pathogen detected Viral pathogen Bacterial pathogen
RSV Influenza Other1 S. pneumo Staph aureus M. tb Hib M. pneum
None (505) 1932 131 40 31 30 0 5 20 55
CHD (137) 59 25 10 9 10 0 2 7 15
CHD with T21 (10) 4 1 1 1 1 0 0 1 1
T21 (25) 10 8 2 1 2 0 0 1 1
ND (25) 10 4 2 0 1 1 1 1 3
ID (7) 0 2 1 0 2 0 1 0 1
Total 278 (39%) 171 (24%) 56 (8%) 42 (6%) 46 (7%) 1 (<1%) 9 (1%) 30 (4%) 76 (11%)

S. pneumo, Streptococcus pneumoniae; Staph aureus, Staphylococcus aureus; M. tb, Mycobacterium tuberculosis; Hib, Haemophilus influenzae b; M. pneum, Mycoplasma pneumoniae.

1

Other viruses = parainfluenza and adenoviruses.

2

Ten children had either S. pneumoniae(5) or H. influenza b(5) isolated from nasopharyngeal aspirates but as this can be part of normal nasopharyngeal flora they were excluded in the totals for bacterial pathogens. None of the 10 had an underlying condition.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

On multivariate analysis, underlying factors associated with prolonged PICU stay included young age, presence of congenital heart disease or cerebral palsy (Table 5A). Fatality was associated with congenital heart disease, Trisomy 21 syndrome, cerebral palsy, and immune deficiency (Table 5B). No relationship was noted between fatality and specific pathogens, laboratory admission or clinical findings on multivariate analysis.

Table 5.

Risk Factors for Length of Stay and Fatality in PICU for Severe Community Acquired Pneumonia in PICU by Multivariate Analysis

Variables β SE Waldχ 2 P OR RR 95%CI
Lower Upper
Risk factors for length of stay
 Age −0.091 0.041 4.837 0.028 0.913 0.843 0.990
 Congenital heart disease 0.857 0.213 16.177 0.000 2.357 1.552 3.580
 Cerebral palsy 1.360 0.491 7.6667 0.006 3.896 1.488 10.203
 Constant −1.174 0.198 35.266 0.000 0.309
Risk factors for fatality
 Congenital heart disease 1.838 0.367 25.009 0.000 6.281 3.057 12.906
 Down syndrome 1.920 0.523 13.462 0.000 6.823 2.446 19.032
 Cerebral palsy 2.162 0.692 9.763 0.002 8.693 2.239 33.750
 Immune deficiency 4.177 0.955 19.127 0.000 65.196 10.027 423.895
 Constant −3.772 0.281 180.082 0.000 0.023

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

DISCUSSION

Severe pneumonia requiring an admission to the PICU represented 7% of all CAP admissions over the 4 years of this prospective study in south China. Very severe CAP occurred most frequently in those under 1 year of age (76%) and one third had underlying or co‐morbid conditions with 21% having congenital heart disease. In 30% of these, the co‐morbid condition was not known prior to PICU admission. The fatality rate was 5.8%. On single factor analysis, PICU admission respiratory rate >70/min, grunting/groaning, head nodding, cyanosis, oxygen saturation <90% and hemoglobin <8 g/dl were each associated with fatality but and on multivariate analysis only the presence of congenital heart disease, Trisomy 21 and immunodeficiency correlated. Neither specific pathogens, nor admission laboratory or presenting clinical findings correlated.

While there are no comparable large cohort studies of very severe CAP being managed in PICU settings in China, India or another developing country, previous reports on CAP or acute lower respiratory infections in children in developing countries have emphasized young age, late hospitalization, changes in sensorium, grunting, head nodding, inability to drink, loose stools, presence of bacteremia, heart disease, anemia, rickets, and lack of breast feeding as predisposing factors for fatality.10, 11, 12, 13, 14, 15, 16, 17, 18, 19 This large PICU cohort study from China provides corroboration for changes in sensorium, high respiratory rate >70/min, grunting/groaning, head nodding and cyanosis as significant clinical predictive factors of fatality on univariate analysis. The major importance of young age noted here and in other studies must not be overlooked.

A number of the factors associated with fatality highlighted in earlier studies noted above were not seen in this PICU cohort study. In part, this may have been because some have been addressed at the population level. For example, no child in this PICU cohort had rickets because vitamin D supplements are routinely given in this area in China. In contrast, rickets was a major associated factor in fatalities in the earlier reports from Yehman.13, 14 Breast feeding is universal in the first year in this region in China so could not be evaluated as an associated risk factor. Bacteremia was detected rarely in this PICU cohort (0.7%) possibly because all had received antibiotics prior to admission to the PICU, even the ones admitted directly to the PICU. Two more recent studies, one from India18 with 200 children reported in 2007 and the other from the Philippines19 with 1,249 children also reported in 2007 have noted the importance of bacteremia (15% and 2.6% respectively). The fatality rate in the study in India was higher than in our PICU cohort (10.5% vs. 5.8%, P < 0.03); but the rate in the very large study from the Philippines was lower (2.6% vs. 5.8%, P < 0.03). However as noted, both of these studies included all children admitted with CAP while ours only included those admitted to PICU making the interpretation of differences more difficult.

The importance of underlying conditions is also noteworthy. In this PICU cohort, 21% had congenital heart disease and in slightly more than one quarter the diagnosis was not made until the child was in the PICU. While 127 of the 200 children in the 2007 Indian CAP study had “no evidence of congenital heart disease,” the actual number with confirmed congenital heart disease is not stated so comparison is not possible. The study from the Philippines also does not specify.

In developing countries with meager resources, care provided by primary village health teams who have received brief and modest training in basic care and appropriate referrals to district health centers has been shown to decrease mortality in the under 5 years age group20 but ready access to tertiary care with a PICU is unlikely in such settings. However, in developing countries with more resources such as Bangladesh, Thailand, and Pakistan who have also used the community health worker model with good outcomes,21 being able to prioritize early those likely in need of the aggressive support available in a PICU might well improve CAP outcomes. Having these community health workers taught how to recognize pneumonia, treat early with simple antibiotics and then refer urgently if signs such as nodding, altered sensorium and/or grunting are present might facilitate more timely presentation to major centers where additional care options such as assisted ventilation in a PICU is possible.

With respect to microbial causes, the relatively high rate of pneumococal and Haemophilus influenzae b infections in this age group is not surprising given that China does not routinely use the vaccines that cover for either. The bacterial cases may well have been underestimated because as noted above all had received antibiotics prior to the blood or endotracheal cultures being collected. A 2009 case control study from Brazil suggests that Haemophilus influenzae b vaccine could prevent an estimated 30% of hospitalized cases of radiologically definite CAP in children under 2 years of age.22 Our earlier prospective study of children hospitalized with CAP in Northwest China also noted H. influenzae b and S. pneumoniae as relatively common pathogens.23 Of note, the World Health Organization Global Action Plan For Prevention and Control of Pnuemonia in 2008 listed immunization coverage for S. pneumoniae and H. influenzae b as well as immunization against measles and pertussis as top prevention strategies.2 This PICU study from China supports the observation from Thailand that Mycoplasma is an important pathogen in children in developing countries hospitalized with CAP including those aged 2–5 years24 and extends it to include those with CAP in the PICU. Mycoplasma was the most common bacterial pathogen detected, found in 11% overall and 47% of those with a bacterial pathogen. No child in this PICU cohort was over 5 years of age.

Respiratory syncytial virus is a well recognized cause of severe respiratory disease in both industrialized as well as developing countries25, 17, 26, 27 particularly in those with underlying conditions such as congenital heart disease.28 In our PICU CAP cohort, respiratory syncytial virus was detected in 23% of the cases and 64% of those in which a virus was found. Twenty percent of those with respiratory syncytial virus also had congenital heart disease. In our previous study of CAP in children hospitalized in northwest China,23 respiratory syncytial virus accounted for 42% of the viral cases and 18% of cases overall.

The impact of influenza may have been underestimated in this PICU CAP cohort in China as pandemic H1N1 cases were excluded from the study as they were felt to be unrepresentative of influenza and hence a year of influenza PICU cases were excluded. Others have noted the importance of non‐pandemic influenza in CAP in developing countries.26, 27 We were not able to corroborate the observation in an industrialized country setting (United States) that children in a PICU with non‐pandemic community acquired influenza with bacterial pneumonia were at marked increase risk for respiratory failure compared to those without bacterial pneumonia.29 This association may not have been seen because of our low numbers of influenza cases (56, 8%) and relatively low rate of bacteremia rate (0.7%).

We were also unable to validate the Bacterial Pneumonia Score developed in Argentina to help distinguish in children with viral from bacterial pneumonia.30 Given that this score was developed for application on CAP admission to hospital and focuses on axillary temperature, white count, percentage of bands and chest radiograph findings, it is not surprising that in children with CAP severe enough to warrant PICU care there might not be as much difference in these factors.

There are other limitations to our study. As noted above, the importance of both common bacteria and influenza may have been underestimated; the former because of antibiotic use prior to cultures being taken and the latter because of exclusion of all pH1N1 cases as unrepresentative. As well the overall repertoire of microbes tested for was limited. Due to cost constraints, neither rhinovirus, human bocavirus, human metapneumovirus, human coronavirus nor Moraxella catarrhalis were tested for although all have been reported in varying rates in children hospitalized with acute respiratory tract infections including CAP31, 32, 33, 34, 35, 36 including two viral studies in China.34, 35, 36 Potential contributing community and family factors were also not examined in our study as this information was not collected. Assessment of factors such as overcrowding and air pollution might be helpful to see if these apply in the PICU CAP patients in the same manner as in children hospitalized with CAP.18, 37

In conclusion, this large cohort study of children with very severe CAP in China has confirmed in a developing country the importance of young age and underlying factors such as congenital heart disease in the most severe cases, that is, those needing PICU support. This study provides yet more evidence on the importance of universal immunization with vaccines against S. pneumoniae and H. influenzae b as recommended by the World Health Organization. Even access to quality PICU support cannot overcome the serious morbidity associated with these bacteria. Prevention is a better option. Countries with emerging economies like India and China need to move forward to provide these two vaccines to all of their children. Beyond this prevention strategy, given the very large numbers of children in China and India and the increasing access to PICUs in many regions early recognition and referral of severe cases may also help to decrease fatalities. More studies are needed to hone best practices for managing pneumonia coming from the community in different developing country settings. This further confirmation that altered sensorium, head nodding and grunting are markers for increased fatality raises the question of whether more training on these markers at the community health worker level can increase recognition and speed of referral for highest risk cases to centers with PICUs.

Conflict of interest: None

REFERENCES

  • 1. Rudan I, Boschi‐Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 2008; 86: 408–416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.World Health Organization, The United Nations Children's Fund (UNICEF). Global action plan for prevention and control of pneumonia. 2009 http://www.who.int/maternal_child_adolescent/documents/fch_cah_nch_09_04/en/index.html Accessed March 19, 2012.
  • 3.International Monetary Fund. World Economic Outlook Database. 5. Report for Selected Countries and Subjects. http://www.imf.org/external/pubs/ft/weo/2012/01/weodata/index.aspx Accessed May 23, 2012.
  • 4. Delport SD, Brisley T. Aetiology and outcome of severe community‐acquired pneumonia in children admitted to a paediatric intensive care unit. S Afr Med J 2002; 92: 907–911. [PubMed] [Google Scholar]
  • 5. Pírez MC, Martínez O, Ferrari AM, Nairac A, Montano A, Rubio I, Saráchaga MJ, Brea S, Picon T, Pinchack MC, et al. Standard case management of pneumonia in hospitalized children in Uruguay, 1997 to 1998. Pediatr Infect Dis J 2001; 20: 283–289. [DOI] [PubMed] [Google Scholar]
  • 6. Duttweiler L, Nadal D, Frey B. Pulmonary and systemic bacterial co‐infections in severe RSV bronchiolitis. Arch Dis Child 2004; 89: 1155–1157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Miles F, Voss L, Segedin E, Anderson BJ. Review of Staphylococcus aureus infections requiring admission to a paediatric intensive care unit. Arch Dis Child 2005; 90: 1274–1278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. World Health Organization . Pocket book of hospital care for children—guidelines for the management of common illnesses with limited resources, Chapter 4. Cough and difficulty breathing. Geneva: WHO; 2005. [Google Scholar]
  • 9. Zar HJ, Jeena P, Argent A, Gie R, Madhi SA, Members of the Working Groups of the Paediatric Assembly of the South African Thoracic Society . Diagnosis and management of community‐acquired pneumonia in childhood—South African Thoracic Society guidelines. S Afr Med J 2005; 95: 977–981, 984–990. [PubMed] [Google Scholar]
  • 10. Deivanayagam N, Nedunchelian K, Ramasamy S, Sudhandirakannan, Ratnam SR. Risk factors for fatal pneumonia: a case control study. Indian Pediatr 1992; 29: 1529–1532. [PubMed] [Google Scholar]
  • 11. Yoon PW, Black RE, Moulton LH, Becker S. Effect of not breast feeding on the risk of diarrheal and respiratory mortality in children under 2 years of age in metro Cebu, the Philippines. Am J Epidemiol 1996; 143: 1142–1148. [DOI] [PubMed] [Google Scholar]
  • 12. Sehgal V, Sethi GR, Sachdev HP, Satayanarayana L. Predictors of mortality in subjects hospitalized with acute lower respiratory tract infections. Indian Pediatr 1997; 34: 213–219. [PubMed] [Google Scholar]
  • 13. Banajeh SM, al‐Sunbali NN, al‐Sanahani SH. Clinical characteristics and outcome of children aged under 5 years hospitalized with severe pneumonia in Yemen. Ann Trop Paediatr 1997; 17: 321–326. [DOI] [PubMed] [Google Scholar]
  • 14. Banajeh SM. Outcome for children under 5 years hospitalized with severe acute lower respiratory tract infections in Yemen: a 5 year experience. J Trop Pediatr 1998; 44: 343–346. [DOI] [PubMed] [Google Scholar]
  • 15. Suwanjutha S, Ruangkanchanasetr S, Chantarojanasiri T, Hotrakitya S. Risk factors associated with morbidity and mortality of pneumonia in Thai children under 5 years. Southeast Asian J Trop Med Public Health 1994; 25: 60–66. [PubMed] [Google Scholar]
  • 16. Demers AM, Morency P, Mberyo‐Yaah F, Jaffar S, Blais C, Somsé P, Bobossi G, Pépin J. Risk factors for mortality among children hospitalized because of acute respiratory infections in Bangui, Central African Republic. Pediatr Infect Dis J 2000; 19: 424–432. [DOI] [PubMed] [Google Scholar]
  • 17. Djelantik IG, Gessner BD, Sutanto A, Steinhoff M, Linehan M, Moulton LH, Arjoso S. Case fatality proportions and predictive factors for mortality among children hospitalized with severe pneumonia in a rural developing country setting. J Trop Pediatr 2003; 49: 327–332. [DOI] [PubMed] [Google Scholar]
  • 18. Tiewsoh K, Lodha R, Pandey RM, Broor S, Kalaivani M, Kabra SK. Factors determining the outcome of children hospitalized with severe pneumonia. BMC Pediatr 2009; 9: 15 DOI: 10.1186/1471-2431-9-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Lupisan SP, Ruutu P, Erma Abucejo‐Ladesma P, Quiambao BP, Gozum L, Sombrero LT, Romano V, Herva E, Riley I, Simoes EA, ARIVAC Consortium . Predictors of death from severe pneumonia among children 2–59 months old hospitalized in Bohol, Philippines: implications for referral criteria at a first‐level health facility. Trop Med Int Health 2007; 12: 962–971. [DOI] [PubMed] [Google Scholar]
  • 20. Brenner JL, Kabakyenga J, Kyomuhangi T, Wotton KA, Pim C, Ntaro M, Bagenda FN, Gad NR, Godel J, Kayizzi J, et al. Can volunteer community health workers decrease child morbidity and mortality in southwestern Uganda? An impact evaluation. PLoS ONE 2011; 6: e27997 DOI: 10.1371/journal.pone.0027997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Global Health Workforce Alliance WHO (2010) Global Experience of Community Health Workers for Delivery of Health Related Millennium Development Goals: a Systematic Review, Country Case Studies, and Recommendations for Integration into National Health Systems. WHO 2010. http://www.who.int/workforcealliance/knowledge/publications/CHW_FullReport_2010.pdf Accessed March 16, 2012.
  • 22. de Andrade AL, de Andrade JG, Martelli CM, e Silva SA, de Oliveira RM, Costa MS, Laval CB, Ribeiro LH, Di Fabio JL. Effectiveness of Haemophilus influenzae b conjugate vaccine on childhood pneumonia: a case‐control study in Brazil. Int J Epidemiol 2004; 33: 173–181. [DOI] [PubMed] [Google Scholar]
  • 23. Zhang Q, Guo Z, MacDonald NE. Vaccine preventable community‐acquired pneumonia in hospitalized children in Northwest China. Pediatr Infect Dis J 2011; 30: 7–10. [DOI] [PubMed] [Google Scholar]
  • 24. Lochindarat S, Suwanjutha S, Prapphal N, Chantarojanasiri T, Bunnag T, Deerojanawong J, Kunakorn M, Srisan P. Mycoplasma pneumoniae and Chlamydophila pneumoniae in children with community‐acquired pneumonia in Thailand. Int J Tuberc Lung Dis 2007; 11: 814–819. [PubMed] [Google Scholar]
  • 25. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009; 360: 588–598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Mathisen M, Basnet S, Sharma A, Shrestha PS, Sharma BN, Valentiner‐Branth P, Sommerfelt H, Strand TA. RNA viruses in young Nepalese children hospitalized with severe pneumonia. Pediatr Infect Dis J 2011; 30: 1032–1036. [DOI] [PubMed] [Google Scholar]
  • 27. Do AH, van Doorn HR, Nghiem MN, Bryant JE, Hoang TH, Do QH, Van TL, Tran TT, Wills B, Nguyen VC, et al. Viral etiologies of acute respiratory infections among hospitalized Vietnamese children in Ho Chi Minh City, 2004–2008. PLoS ONE 2011; 6: e18176 DOI: 10.1371/journal.pone.0018176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Welliver RC, Sr. , Checchia PA, Bauman JH, Fernandes AW, Mahadevia PJ, Hall CB. Fatality rates in published reports of RSV hospitalizations among high‐risk and otherwise healthy children. Curr Med Res Opin 2010; 26: 2175–2181. [DOI] [PubMed] [Google Scholar]
  • 29. Spaeder MC, Milstone AM, Fackler JC. Association of bacterial pneumonia and respiratory failure in children with community‐acquired influenza infection. Pediatr Crit Care Med 2011; 12: e181–e183. [DOI] [PubMed] [Google Scholar]
  • 30. Moreno L, Krishnan JA, Duran P, Ferrero F. Development and validation of a clinical prediction rule to distinguish bacterial from viral pneumonia in children. Pediatr Pulmonol 2006; 41: 331–337. [DOI] [PubMed] [Google Scholar]
  • 31. Nascimento‐Carvalho CM, Cardoso MR, Meriluoto M, Kemppainen K, Kantola K, Ruuskanen O, Hedman K, Söderlund‐Venermo M. Human bocavirus infection diagnosed serologically among children admitted to hospital with community‐acquired pneumonia in a tropical region. J Med Virol 2012; 84: 253–258. [DOI] [PubMed] [Google Scholar]
  • 32. Honkinen M, Lahti E, Osterback R, Ruuskanen O, Waris M. Viruses and bacteria in sputum samples of children with community‐acquired pneumonia. Clin Microbiol Infect 2012; 18: 300–307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Nascimento‐Carvalho CM, Cardoso MR, Ruuskanen O, Lappalainen M. Sole infection by human metapneumovirus among children with radiographically diagnosed community‐acquired pneumonia in a tropical region. Influenza Other Respi Viruses 2011; 5: 285–287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Zeng M, Zhu QR, Wang XH, Yu H, Shen J. Human bocavirus in children with respiratory tract infection in Shanghai: a retrospective study. World J Pediatr 2010; 6: 65–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Jin Y, Zhang RF, Xie ZP, Yan KL, Gao HC, Song JR, Yuan XH, Cheng WX, Hou YD, Duan ZJ. Newly identified respiratory viruses associated with acute lower respiratory tract infections in children in Lanzou, China, from 2006 to 2009. Clin Microbiol Infect 2012; 18: 74–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Cui LJ, Zhang C, Zhang T, Lu RJ, Xie ZD, Zhang LL, Liu CY, Zhou WM, Ruan L, Ma XJ, et al. Human Coronaviruses HCoV‐NL63 and HCoV‐HKU1 in hospitalized children with acute respiratory infections in Beijing, China. Adv Virol 2011; 2011: 129–134. DOI: 10.1155/2011/129134 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Smith KR, McCracken JP, Weber MW, Hubbard A, Jenny A, Thompson LM, Balmes J, Diaz A, Arana B, Bruce N. Effect of reduction in household air pollution on childhood pneumonia in Guatemala (RESPIRE): a randomised controlled trial. Lancet 2011; 378: 1717–1726. [DOI] [PubMed] [Google Scholar]

Articles from Pediatric Pulmonology are provided here courtesy of Wiley

RESOURCES